Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
New World alphavirus multivalent vaccine
- Development stage
- Preclinical
- Lead developer
- Hawaii Biotech
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
New World alphavirus multivalent vaccine is a **multivalent recombinant subunit protein vaccine** being developed by Hawaii Biotech for prophylaxis against major New World equine encephalitis alphaviruses. The candidate is described as combining antigens from **Venezuelan equine encephalitis virus**, **Eastern equine encephalitis virus**, and **Western equine encephalitis virus** to induce protective immunity against the corresponding encephalitic diseases. Based on the provided pipeline context, it is a **preclinical vaccine program** and appears intended as a broad-spectrum alphavirus immunization approach rather than a therapeutic product.
- Other names
- New World Alphavirus vaccine
02
Targets
EEEV antigen (Eastern equine encephalitis virus antigen)VEEV E polyprotein (Venezuelan equine encephalitis virus envelope polyprotein)WEEV structural protein (Western equine encephalitis virus structural polyprotein)
Beyond the preview
Go deeper on New World alphavirus multivalent vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on New World alphavirus multivalent vaccine.